• Boris Peaker, Ph.D., CFA

    Cowen & Co
    • Debjit Chattopadhyay, Ph.D.

      H.C. Wainwright & Co.
      • Jessica Fye

        J.P. Morgan
        • Jonathan Chang, Ph.D., CFA

          Leerink Partners
          • Michael Ulz

            Robert W. Baird
            • David Nierengarten, Ph.D.


              Mersana Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Mersana Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Mersana Therapeutics or its management. Mersana Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.